America Handing MRNA Lead: Investors Reassess Biotech
A political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
Take advantage of free courses on financial planning for beginners to boost your financial knowledge. Start your learning journey today.
10,572 articlesA political shift in the United States is denting confidence in mRNA medicine, with funding drying up and manufacturi...
A New Mexico verdict against Meta and a California ruling involving Meta and YouTube mark a turning point in lawsuits...
Gen Z buyers are turning to Midwest towns where median prices sit well below coastal metros. This shift signals a maj...
A new partnership could let borrowers pledge crypto as collateral for home loans. This article breaks down how crypto...
A new science council linked to Trump signals a stronger link between AI and crypto policy. This morning minute exami...
Investors are weighing the beads-and-blood-screening company Cytosorbents as it reports 2025 earnings. This guide bre...
Cathie Wood's bold bets launched a new era for ETFs. This piece explains how ARK helped fuel demand for active ETFs, ...
MARA Holdings sold roughly 15,133 BTC for $1.1 billion to buy back convertible notes and trim debt, a move that reduc...
In his first week as Disney’s leader, Josh D’Amaro confronts three major headwinds that could set the tone for his te...
This analysis dives into worksport (wksp) 2025 earnings, decoding the Q4 2025 transcript. Learn how revenue, margins,...
Lucid Diagnostics (LUCD) is navigating reimbursement and adoption as it scales its non-invasive tests. This analysis ...
Tether plans a full-scale audit of USDT reserves by a Big Four firm, moving from attestations to a formal audit and s...